D.E. Shaw & Co
TFFP

D.E. Shaw & Co’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

D.E. Shaw & Co’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-564
Closed -$136K – 5298
2021
Q2 		$136K Buy
+564
New +$155K ﹤0.01% 4513

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

D.E. Shaw & Co's TFFP Position: Q3 2021 in Review

D.E. Shaw & Co sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 564 shares — an estimated $136K sold.

D.E. Shaw & Co first reported a position in TFFP in Q2 2021 and held it in 1 quarter. The position peaked at $136K in Q2 2021. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • D.E. Shaw & Co reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 564 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $136K.
  • D.E. Shaw & Co first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's TFF Pharmaceuticals, Inc. Common Stock position peaked at $136K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.